Retrospective cohort links immune checkpoint inhibitor–containing chemoimmunotherapy to longer overall survival in recurrent nasopharyngeal carcinoma
A 37-patient retrospective cohort found that immune checkpoint inhibitor–containing chemoimmunotherapy was associated with longer overall survival than chemotherapy alone in ...
